Adaptimmune Therapeutics
ADAP
#9234
Rank
C$0.10 B
Marketcap
$0.38
Share price
4.45%
Change (1 day)
-75.64%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -C$92.86 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are C$0.17 Billion. , an increase over its 2023 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -C$90.15 Million-41.87%
2023 -C$0.16 Billion-30.65%
2022 -C$0.23 Billion-0.36%
2021 -C$0.23 Billion21.62%
2020 -C$0.19 Billion-4.55%
2019 -C$0.2 Billion69%
2018 -C$0.12 Billion-7.47%
2017 -C$0.13 Billion24.71%
2016 -C$99.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.22 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$10.51 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.35 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$0.94 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA